BioNTech SE (BNTX) Divestments (2019 - 2025)
BioNTech SE (BNTX) posted Divestments of -$1.1 billion for Q3 2025, down 1383.89% on a QoQ basis from -$72.9 million in Q2 2025, and down 593.16% year-over-year from $219.3 million in Q3 2024.
BioNTech SE (BNTX) has 7 years of Divestments data on file, last reported at -$1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.08 Bn |
| Jun 30, 2025 | -72.90 Mn |
| Mar 31, 2025 | 1.31 Bn |
| Sep 30, 2024 | -156.06 Mn |
| Jun 30, 2024 | -259.96 Mn |
| Mar 31, 2024 | -2.50 Bn |
| Sep 30, 2023 | -1.34 Bn |
| Jun 30, 2023 | -2.50 Bn |
| Mar 31, 2023 | -789.34 Mn |
| Sep 30, 2022 | -83.99 Mn |
| Jun 30, 2022 | -83.66 Mn |
| Mar 31, 2022 | 322.56 Mn |
| Sep 30, 2021 | 481.27 Mn |
| Jun 30, 2021 | 35.89 Mn |
| Mar 31, 2021 | 34.14 |
| Sep 30, 2020 | 487.56 Mn |
| Jun 30, 2020 | -10.79 Mn |
| Mar 31, 2020 | -16.49 Mn |
| Mar 31, 2019 | -37.70 Mn |